We measured cerebral blood flow and somatosensory evoked potentials during transient focal cerebral ischemia in cats to compare the effects of four commonly used anesthetic regimens: ketamine/fentanyl/N 2 O (fentanyl), pentobarbital, ketamine/o^chloralose (cv-chloralose), and ketamine/halothane/N 2 O (halothane). Six cats in each group were subjected to 60 minutes of left middle cerebral artery occlusion followed by 120 minutes of reperfusion. Although the amplitude of the initial somatosensory evoked potential wave complex was highest in the tt-chloralose group (58.6±16.5 /iX) and smallest in the halothane group (27J±5.7 fiV), amplitude fell by 75% in all groups upon occlusion. Baseline cerebral blood flow varied substantially between groups (e.g., in the right intersylvian gyrus: fentanyl, 96 ±12; pentobarbital, 30±5; o-chloralose, 24±3; and halothane, 76±11 ml/min/100 g). Occlusion decreased cerebral blood flow to subcortical (e.g., left caudate) structures in all groups (fentanyl, 29±11%; pentobabital, 45±12%; o-chloralose, 27±13%; and halothane, 18±5% of baseline). Postischemic hyperemia occurred in the cortical regions of cats anesthetized with pentobarbital or «-chloralose that had reduced cerebral blood flows during occlusion but not in cats anesthetized with fentanyl (cerebral blood flow during occlusion not different from that of cats anesthetized with pentobarbital or . occlusion has been used by many laboratories, 1 -5 cerebral blood flow (CBF), cerebral metabolic rate for oxygen (CMRO 2 ), and histologic patterns have been difficult to compare among laboratories. This difficulty results in part from not knowing whether differences in results can be attributed to differences in anesthetics, species, or models.Anesthetics (e.g., pentobarbital, ketamine/achloralose, and ketamine/halothane/r^O), Received April 26, 1989; accepted January 11, 1990. evoked potentials. For example, pentobarbital decreases CBF, CMRO 2 , 7 and the amplitude of somatosensory evoked potentials.8 Ketamine increases CBF, has variable effects on CMRO2, 9 and increases the amplitude of somatosensory evoked potentials.10 The effect of a-chloralose upon CMRO2, CBF, and baseline electrophysiologic parameters has not been well studied. Halothane increases CBF, decreases CMRO2, 11 decreases the amplitude, and increases the latency of somatosensory evoked potentials.12 N 2 O increases CMRO 2 13 and C B F 4 and decreases the amplitude of soma...